Loading patent…
AssigneeHybridon, Inc.
InventorsPETER C ROBERT, BRUCE L. FRANK, DAVID E. SZYMKOWSKI, JOHN S. MILLS, JOHN GOODCHILD, JIA L. WOLFE, ROBERT E. KILKUSKIE, ISOBEL M. GREENFIELD, VERONIA SULLIVAN
Estimating the term…
The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.
A synthetic oligonucleotide which is complementary to a nucleic acid sequence spanning the translational start site of human papillomavirus gene E1, and which includes at least 15 nucleotides.
Dependencies are inferred from the claim text.